Description:2,300 is today's daily digit in Europe - the number of jobs being cut at AstraZeneca. It's all part of the new chief executive's plan to return the struggling drugmaker to growth. Pascal Soriot wants to focus research on three main areas - including cancer, cardiovascular disorders and respiratory diseases. He also hoping to find new business partners to replenish a sparse new drug pipeline. But it looks like being a long haul.(1:00)